The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Abbott Laboratories | Common | 002824100 | 28,737 | 391,719 | SH | SOLE | 391,719 | 0 | 0 | ||
AbbVie Inc. | Common | 00287Y109 | 46,541 | 492,078 | SH | SOLE | 492,078 | 0 | 0 | ||
ABIOMED, Inc. | Common | 003654100 | 1,687 | 3,750 | SH | SOLE | 3,750 | 0 | 0 | ||
AC Immune SA | Shares | H00263105 | 1,375 | 171,813 | SH | SOLE | 171,813 | 0 | 0 | ||
Acadia Healthcare Company, Inc. | Common | 00404A109 | 9,588 | 272,400 | SH | SOLE | 272,400 | 0 | 0 | ||
ACADIA Pharmaceuticals Inc. | Common | 004225108 | 1,945 | 93,689 | SH | SOLE | 93,689 | 0 | 0 | ||
Acceleron Pharma Inc. | Common | 00434H108 | 9,773 | 170,766 | SH | SOLE | 170,766 | 0 | 0 | ||
Achillion Pharmaceuticals, Inc. | Common | 00448Q201 | 1,710 | 464,761 | SH | SOLE | 464,761 | 0 | 0 | ||
Adaptimmune Therapeutics plc | Sponsored ADR | 00653A107 | 4,768 | 351,618 | SH | SOLE | 351,618 | 0 | 0 | ||
Aegerion Pharmaceuticals, Inc. | Note 2.00% 8/15/19 | 00767EAB8 | 9,740 | 13,000,000 | PRN | SOLE | 13,000,000 | 0 | 0 | ||
Aerie Pharmaceuticals, Inc. | Common | 00771V108 | 2,386 | 38,770 | SH | SOLE | 38,770 | 0 | 0 | ||
Aerpio Pharmaceuticals, Inc. | Common | 00810B105 | 2,364 | 765,000 | SH | SOLE | 765,000 | 0 | 0 | ||
Aetna Inc. | Common | 00817Y108 | 16,966 | 83,637 | SH | SOLE | 83,637 | 0 | 0 | ||
Affimed NV | Common | N01045108 | 1,105 | 254,000 | SH | SOLE | 254,000 | 0 | 0 | ||
Agilent Technologies, Inc. | Common | 00846U101 | 4,007 | 56,800 | SH | SOLE | 56,800 | 0 | 0 | ||
Agios Pharmaceuticals, Inc. | Common | 00847X104 | 2,612 | 33,870 | SH | SOLE | 33,870 | 0 | 0 | ||
Akebia Therapeutics, Inc. | Common | 00972D105 | 2,354 | 266,612 | SH | SOLE | 266,612 | 0 | 0 | ||
Albireo Pharma, Inc. | Common | 01345P106 | 4,120 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
Alexion Pharmaceuticals, Inc. | Common | 015351109 | 60,944 | 438,416 | SH | SOLE | 438,416 | 0 | 0 | ||
Align Technology, Inc. | Common | 016255101 | 4,399 | 11,244 | SH | SOLE | 11,244 | 0 | 0 | ||
Alkermes plc | Shares | G01767105 | 7,259 | 171,042 | SH | SOLE | 171,042 | 0 | 0 | ||
Allergan plc | Shares | G0177J108 | 47,398 | 248,836 | SH | SOLE | 248,836 | 0 | 0 | ||
Alliqua BioMedical, Inc. | Common | 019621309 | 375 | 165,000 | SH | SOLE | 165,000 | 0 | 0 | ||
Alnylam Pharmaceuticals, Inc. | Common | 02043Q107 | 11,043 | 126,176 | SH | SOLE | 126,176 | 0 | 0 | ||
Amarin Corporation plc | Sponsored ADR | 023111206 | 12,268 | 754,049 | SH | SOLE | 754,049 | 0 | 0 | ||
AmerisourceBergen Corporation | Common | 03073E105 | 10,311 | 111,807 | SH | SOLE | 111,807 | 0 | 0 | ||
Amgen Inc. | Common | 031162100 | 140,513 | 677,855 | SH | SOLE | 677,855 | 0 | 0 | ||
Amicus Therapeutics, Inc. | Common | 03152W109 | 10,582 | 875,304 | SH | SOLE | 875,304 | 0 | 0 | ||
AnaptysBio, Inc. | Common | 032724106 | 4,580 | 45,910 | SH | SOLE | 45,910 | 0 | 0 | ||
Anthem, Inc. | Common | 036752103 | 38,681 | 141,147 | SH | SOLE | 141,147 | 0 | 0 | ||
ARCA biopharma, Inc. | Common | 00211Y407 | 454 | 811,227 | SH | SOLE | 811,227 | 0 | 0 | ||
Ardelyx, Inc. | Common | 039697107 | 2,781 | 639,370 | SH | SOLE | 639,370 | 0 | 0 | ||
Arena Pharmaceuticals, Inc. | Common | 040047607 | 4,315 | 93,767 | SH | SOLE | 93,767 | 0 | 0 | ||
argenx SE | Sponsored ADR | 04016X101 | 1,152 | 15,188 | SH | SOLE | 15,188 | 0 | 0 | ||
ArQule, Inc. | Common | 04269E107 | 1,415 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
Array BioPharma Inc. | Common | 04269X105 | 5,535 | 364,166 | SH | SOLE | 364,166 | 0 | 0 | ||
Ascendis Pharma A/S | Sponsored ADR | 04351P101 | 4,656 | 65,714 | SH | SOLE | 65,714 | 0 | 0 | ||
Assertio Therapeutics, Inc. | Common | 04545L107 | 6 | 1,000 | SH | SOLE | 1,000 | 0 | 0 | ||
AstraZeneca PLC | Sponsored ADR | 046353108 | 28,436 | 718,624 | SH | SOLE | 718,624 | 0 | 0 | ||
Athenex, Inc. | Common | 04685N103 | 708 | 45,530 | SH | SOLE | 45,530 | 0 | 0 | ||
Audentes Therapeutics, Inc. | Common | 05070R104 | 1,534 | 38,740 | SH | SOLE | 38,740 | 0 | 0 | ||
Avadel Pharmaceuticals plc | Sponsored ADR | 05337M104 | 3,576 | 814,588 | SH | SOLE | 814,588 | 0 | 0 | ||
Bausch Health Companies Inc. | Common | 071734107 | 4,929 | 192,000 | SH | SOLE | 192,000 | 0 | 0 | ||
Baxter International Inc. | Sponsored ADR | 071813109 | 11,258 | 146,040 | SH | SOLE | 146,040 | 0 | 0 | ||
Becton, Dickinson and Company | Common | 075887109 | 16,750 | 64,178 | SH | SOLE | 64,178 | 0 | 0 | ||
BeiGene, Ltd. | Sponsored ADR | 07725L102 | 14,769 | 85,755 | SH | SOLE | 85,755 | 0 | 0 | ||
Bellicum Pharmaceuticals, Inc. | Common | 079481107 | 370 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
Biogen Inc. | Common | 09062X103 | 138,286 | 391,402 | SH | SOLE | 391,402 | 0 | 0 | ||
BioMarin Pharmaceutical Inc. | Common | 09061G101 | 13,628 | 140,538 | SH | SOLE | 140,538 | 0 | 0 | ||
bluebird bio, Inc. | Common | 09609G100 | 12,817 | 87,788 | SH | SOLE | 87,788 | 0 | 0 | ||
Blueprint Medicines Corporation | Common | 09627Y109 | 11,397 | 146,001 | SH | SOLE | 146,001 | 0 | 0 | ||
Boston Scientific Corporation | Common | 101137107 | 17,132 | 444,991 | SH | SOLE | 444,991 | 0 | 0 | ||
Bristol-Myers Squibb Company | Common | 110122108 | 22,725 | 366,064 | SH | SOLE | 366,064 | 0 | 0 | ||
Cardinal Health, Inc. | Common | 14149Y108 | 340 | 6,300 | SH | SOLE | 6,300 | 0 | 0 | ||
Celgene Corporation | Common | 151020104 | 117,442 | 1,312,350 | SH | SOLE | 1,312,350 | 0 | 0 | ||
Celldex Therapeutics, Inc. | Common | 15117B103 | 48 | 105,800 | SH | SOLE | 105,800 | 0 | 0 | ||
Cellectis SA | Sponsored ADR | 15117K103 | 7,873 | 278,988 | SH | SOLE | 278,988 | 0 | 0 | ||
Centene Corporation | Common | 15135B101 | 24,159 | 166,869 | SH | SOLE | 166,869 | 0 | 0 | ||
Charles River Laboratories International, Inc. | Common | 159864107 | 3,050 | 22,670 | SH | SOLE | 22,670 | 0 | 0 | ||
Cidara Therapeutics, Inc. | Common | 171757107 | 699 | 158,784 | SH | SOLE | 158,784 | 0 | 0 | ||
Cigna Corporation | Common | 125509109 | 8,426 | 40,461 | SH | SOLE | 40,461 | 0 | 0 | ||
Clearside Biomedical, Inc. | Common | 185063104 | 508 | 82,665 | SH | SOLE | 82,665 | 0 | 0 | ||
Clovis Oncology, Inc. | Common | 189464100 | 2,214 | 75,400 | SH | SOLE | 75,400 | 0 | 0 | ||
Coherus Biosciences, Inc. | Common | 19249H103 | 2,472 | 149,820 | SH | SOLE | 149,820 | 0 | 0 | ||
Community Health Systems, Inc. | Common | 203668108 | 706 | 203,935 | SH | SOLE | 203,935 | 0 | 0 | ||
Concert Pharmaceuticals, Inc. | Common | 206022105 | 1,346 | 90,724 | SH | SOLE | 90,724 | 0 | 0 | ||
CRISPR Therapeutics AG | Common | H17182108 | 7,910 | 178,348 | SH | SOLE | 178,348 | 0 | 0 | ||
CVS Health Corporation | Common | 126650100 | 31,575 | 401,101 | SH | SOLE | 401,101 | 0 | 0 | ||
CymaBay Therapeutics, Inc. | Common | 23257D103 | 1,883 | 169,962 | SH | SOLE | 169,962 | 0 | 0 | ||
Danaher Corporation | Common | 235851102 | 22,750 | 209,371 | SH | SOLE | 209,371 | 0 | 0 | ||
DENTSPLY SIRONA Inc. | Common | 24906P109 | 2,174 | 57,600 | SH | SOLE | 57,600 | 0 | 0 | ||
Dermira, Inc. | Common | 24983L104 | 2,553 | 234,200 | SH | SOLE | 234,200 | 0 | 0 | ||
Diplomat Pharmacy, Inc. | Common | 25456K101 | 8,521 | 439,001 | SH | SOLE | 439,001 | 0 | 0 | ||
Editas Medicine, Inc. | Common | 28106W103 | 2,440 | 76,668 | SH | SOLE | 76,668 | 0 | 0 | ||
Edwards Lifesciences Corporation | Common | 28176E108 | 13,353 | 76,696 | SH | SOLE | 76,696 | 0 | 0 | ||
Egalet Corporation | Note 5.50% 4/1/20 | 28226BAB0 | 700 | 7,000,000 | PRN | SOLE | 7,000,000 | 0 | 0 | ||
Eidos Therapeutics, Inc. | Common | 28249H104 | 278 | 27,900 | SH | SOLE | 27,900 | 0 | 0 | ||
Eli Lilly and Company | Common | 532457108 | 23,226 | 216,442 | SH | SOLE | 216,442 | 0 | 0 | ||
Endo International plc | Shares | G30401106 | 17,151 | 1,019,048 | SH | SOLE | 1,019,048 | 0 | 0 | ||
Endocyte, Inc. | Common | 29269A102 | 746 | 41,980 | SH | SOLE | 41,980 | 0 | 0 | ||
Epizyme, Inc. | Common | 29428V104 | 5,144 | 485,325 | SH | SOLE | 485,325 | 0 | 0 | ||
Esperion Therapeutics, Inc. | Common | 29664W105 | 8,399 | 189,287 | SH | SOLE | 189,287 | 0 | 0 | ||
Evolent Health, Inc. | Common | 30050B101 | 2,394 | 84,300 | SH | SOLE | 84,300 | 0 | 0 | ||
Exelixis, Inc. | Common | 30161Q104 | 9,816 | 553,940 | SH | SOLE | 553,940 | 0 | 0 | ||
Express Scripts Holding Company | Common | 30219G108 | 5,059 | 53,250 | SH | SOLE | 53,250 | 0 | 0 | ||
FibroGen, Inc. | Common | 31572Q808 | 10,826 | 178,207 | SH | SOLE | 178,207 | 0 | 0 | ||
Foamix Pharmaceuticals Ltd. | Shares | M46135105 | 4,167 | 727,205 | SH | SOLE | 727,205 | 0 | 0 | ||
Galapagos NV | Sponsored ADR | 36315X101 | 11,222 | 99,815 | SH | SOLE | 99,815 | 0 | 0 | ||
Genomic Health, Inc. | Common | 37244C101 | 2,439 | 34,740 | SH | SOLE | 34,740 | 0 | 0 | ||
Gilead Sciences, Inc. | Common | 375558103 | 149,966 | 1,942,317 | SH | SOLE | 1,942,317 | 0 | 0 | ||
GlaxoSmithKline plc | Shares | 37733W105 | 8,785 | 218,700 | SH | SOLE | 218,700 | 0 | 0 | ||
Global Blood Therapeutics, Inc. | Common | 37890U108 | 5,026 | 132,270 | SH | SOLE | 132,270 | 0 | 0 | ||
Global Medical REIT Inc. | Common | 37954A204 | 691 | 73,400 | SH | SOLE | 73,400 | 0 | 0 | ||
GW Pharmaceuticals plc | ADS | 36197T103 | 7,531 | 43,598 | SH | SOLE | 43,598 | 0 | 0 | ||
HCA Healthcare, Inc. | Common | 40412C101 | 10,341 | 74,335 | SH | SOLE | 74,335 | 0 | 0 | ||
HCP, Inc. | Common | 40414L109 | 1,198 | 45,500 | SH | SOLE | 45,500 | 0 | 0 | ||
Healthcare Realty Trust Incorporated | Common | 421946104 | 1,990 | 68,000 | SH | SOLE | 68,000 | 0 | 0 | ||
Healthcare Trust of America, Inc. | Common | 42225P501 | 1,227 | 46,000 | SH | SOLE | 46,000 | 0 | 0 | ||
Henry Schein, Inc. | Common | 806407102 | 2,670 | 31,400 | SH | SOLE | 31,400 | 0 | 0 | ||
Hologic, Inc. | Common | 436440101 | 801 | 19,546 | SH | SOLE | 19,546 | 0 | 0 | ||
Horizon Pharma plc | Shares | G4617B105 | 3,190 | 162,900 | SH | SOLE | 162,900 | 0 | 0 | ||
Humana Inc. | Common | 444859102 | 23,184 | 68,487 | SH | SOLE | 68,487 | 0 | 0 | ||
IDEXX Laboratories, Inc. | Common | 45168D104 | 25,566 | 102,403 | SH | SOLE | 102,403 | 0 | 0 | ||
Illumina, Inc. | Common | 452327109 | 89,092 | 242,717 | SH | SOLE | 242,717 | 0 | 0 | ||
ImmunoGen, Inc. | Common | 45253H101 | 1,593 | 168,190 | SH | SOLE | 168,190 | 0 | 0 | ||
Immunomedics, Inc. | Common | 452907108 | 2,028 | 97,370 | SH | SOLE | 97,370 | 0 | 0 | ||
Incyte Corporation | Common | 45337C102 | 44,587 | 645,442 | SH | SOLE | 645,442 | 0 | 0 | ||
Innoviva, Inc. | Common | 45781M101 | 2,463 | 161,603 | SH | SOLE | 161,603 | 0 | 0 | ||
Inovalon Holdings, Inc. | Common | 45781D101 | 1,770 | 176,163 | SH | SOLE | 176,163 | 0 | 0 | ||
Intellia Therapeutics, Inc. | Common | 45826J105 | 1,965 | 68,671 | SH | SOLE | 68,671 | 0 | 0 | ||
Intersect ENT, Inc. | Common | 46071F103 | 240 | 8,356 | SH | SOLE | 8,356 | 0 | 0 | ||
Intra-Cellular Therapies, Inc. | Common | 46116X101 | 756 | 34,850 | SH | SOLE | 34,850 | 0 | 0 | ||
Intuitive Surgical, Inc. | Common | 46120E602 | 14,137 | 24,629 | SH | SOLE | 24,629 | 0 | 0 | ||
Ionis Pharmaceuticals, Inc. | Common | 462222100 | 4,273 | 82,838 | SH | SOLE | 82,838 | 0 | 0 | ||
Iovance Biotherapeutics, Inc. | Common | 462260100 | 2,440 | 216,908 | SH | SOLE | 216,908 | 0 | 0 | ||
IQVIA Holdings Inc. | Common | 46266C105 | 2,180 | 16,800 | SH | SOLE | 16,800 | 0 | 0 | ||
Jazz Pharmaceuticals plc | Shares | G50871105 | 18,570 | 110,452 | SH | SOLE | 110,452 | 0 | 0 | ||
Johnson & Johnson | Common | 478160104 | 137,751 | 996,968 | SH | SOLE | 996,968 | 0 | 0 | ||
Jounce Therapeutics, Inc. | Common | 481116101 | 66 | 10,127 | SH | SOLE | 10,127 | 0 | 0 | ||
Koninklijke Philips N.V. | NY Reg Sh | 500472303 | 1,506 | 33,100 | SH | SOLE | 33,100 | 0 | 0 | ||
Laboratory Corporation of America Holdings | Sponsored ADR | 50540R409 | 2,119 | 12,200 | SH | SOLE | 12,200 | 0 | 0 | ||
LeMaitre Vascular, Inc. | Common | 525558201 | 1,052 | 27,150 | SH | SOLE | 27,150 | 0 | 0 | ||
Lexicon Pharmaceuticals, Inc. | Sponsored ADR | 528872302 | 747 | 70,000 | SH | SOLE | 70,000 | 0 | 0 | ||
Ligand Pharmaceuticals Incorporated | Common | 53220K504 | 2,454 | 8,940 | SH | SOLE | 8,940 | 0 | 0 | ||
LivaNova plc | Shares | G5509L101 | 779 | 6,287 | SH | SOLE | 6,287 | 0 | 0 | ||
Loxo Oncology, Inc. | Common | 548862101 | 4,202 | 24,595 | SH | SOLE | 24,595 | 0 | 0 | ||
LTC Properties, Inc. | Common | 502175102 | 9,249 | 209,673 | SH | SOLE | 209,673 | 0 | 0 | ||
Madrigal Pharmaceuticals, Inc. | Common | 558868105 | 1,428 | 6,670 | SH | SOLE | 6,670 | 0 | 0 | ||
Mallinckrodt plc | Shares | G5785G107 | 1,571 | 53,600 | SH | SOLE | 53,600 | 0 | 0 | ||
Marinus Pharmaceuticals, Inc. | Common | 56854Q101 | 3,362 | 336,228 | SH | SOLE | 336,228 | 0 | 0 | ||
Masimo Corporation | Common | 574795100 | 4,237 | 34,020 | SH | SOLE | 34,020 | 0 | 0 | ||
McKesson Corporation | Common | 58155Q103 | 11,003 | 82,947 | SH | SOLE | 82,947 | 0 | 0 | ||
Medical Properties Trust, Inc. | Common | 58463J304 | 7,118 | 477,409 | SH | SOLE | 477,409 | 0 | 0 | ||
The Medicines Company | Common | 584688105 | 4,960 | 165,841 | SH | SOLE | 165,841 | 0 | 0 | ||
Medtronic plc | Shares | G5960L103 | 33,391 | 339,439 | SH | SOLE | 339,439 | 0 | 0 | ||
Menlo Therapeutics Inc. | Common | 586858102 | 244 | 24,784 | SH | SOLE | 24,784 | 0 | 0 | ||
Merck & Co., Inc. | Common | 58933Y105 | 45,771 | 645,208 | SH | SOLE | 645,208 | 0 | 0 | ||
Merus N.V. | Common | N5749R100 | 8,175 | 414,115 | SH | SOLE | 414,115 | 0 | 0 | ||
Mettler-Toledo International Inc. | Common | 592688105 | 2,131 | 3,500 | SH | SOLE | 3,500 | 0 | 0 | ||
Mirati Therapeutics, Inc. | Common | 60468T105 | 640 | 13,590 | SH | SOLE | 13,590 | 0 | 0 | ||
Molecular Templates, Inc. | Common | 608550109 | 777 | 144,110 | SH | SOLE | 144,110 | 0 | 0 | ||
Mylan N.V. | Shares | N59465109 | 60,647 | 1,657,017 | SH | SOLE | 1,657,017 | 0 | 0 | ||
MyoKardia, Inc. | Common | 62857M105 | 2,517 | 38,600 | SH | SOLE | 38,600 | 0 | 0 | ||
Nektar Therapeutics | Common | 640268108 | 12,952 | 212,469 | SH | SOLE | 212,469 | 0 | 0 | ||
Neurocrine Biosciences, Inc. | Common | 64125C109 | 26,143 | 212,630 | SH | SOLE | 212,630 | 0 | 0 | ||
Nevro Corp. | Common | 64157F103 | 3,919 | 68,760 | SH | SOLE | 68,760 | 0 | 0 | ||
New Senior Investment Group Inc. | Common | 648691103 | 3,121 | 528,919 | SH | SOLE | 528,919 | 0 | 0 | ||
NewLink Genetics Corporation | Common | 651511107 | 490 | 205,026 | SH | SOLE | 205,026 | 0 | 0 | ||
Nightstar Therapeutics plc | ADR | 65413A101 | 3,065 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
Novartis AG | Sponsored ADR | 66987V109 | 27,803 | 322,690 | SH | SOLE | 322,690 | 0 | 0 | ||
Novavax, Inc. | Common | 670002104 | 1,073 | 571,000 | SH | SOLE | 571,000 | 0 | 0 | ||
Novo Nordisk A/S | Sponsored ADR | 670100205 | 14,232 | 301,900 | SH | SOLE | 301,900 | 0 | 0 | ||
NuCana plc | Sponsored ADR | 67022C106 | 245 | 9,823 | SH | SOLE | 9,823 | 0 | 0 | ||
NuVasive, Inc. | Common | 670704105 | 1,390 | 19,580 | SH | SOLE | 19,580 | 0 | 0 | ||
Omega Healthcare Investors, Inc. | Common | 681936100 | 19,000 | 579,785 | SH | SOLE | 579,785 | 0 | 0 | ||
Ovid Therapeutics Inc. | Common | 690469101 | 3,038 | 535,824 | SH | SOLE | 535,824 | 0 | 0 | ||
Perrigo Company plc | Shares | G97822103 | 2,641 | 37,300 | SH | SOLE | 37,300 | 0 | 0 | ||
Pfizer Inc. | Common | 717081103 | 59,675 | 1,354,093 | SH | SOLE | 1,354,093 | 0 | 0 | ||
Physicians Realty Trust | Common | 71943U104 | 6,593 | 391,016 | SH | SOLE | 391,016 | 0 | 0 | ||
Pieris Pharmaceuticals, Inc. | Common | 720795103 | 11,689 | 2,087,380 | SH | SOLE | 2,087,380 | 0 | 0 | ||
Portola Pharmaceuticals, Inc. | Sponsored ADR | 737010108 | 3,074 | 115,448 | SH | SOLE | 115,448 | 0 | 0 | ||
PRA Health Sciences, Inc. | Common | 69354M108 | 3,577 | 32,460 | SH | SOLE | 32,460 | 0 | 0 | ||
Protagonist Therapeutics, Inc. | Common | 74366E102 | 2,254 | 219,042 | SH | SOLE | 219,042 | 0 | 0 | ||
PTC Therapeutics, Inc. | Common | 69366J200 | 2,274 | 48,390 | SH | SOLE | 48,390 | 0 | 0 | ||
Puma Biotechnology, Inc. | Common | 74587V107 | 3,821 | 83,340 | SH | SOLE | 83,340 | 0 | 0 | ||
Quest Diagnostics Incorporated | Common | 74834L100 | 4,208 | 39,000 | SH | SOLE | 39,000 | 0 | 0 | ||
Quorum Health Corporation | Common | 74909E106 | 139 | 23,725 | SH | SOLE | 23,725 | 0 | 0 | ||
Regeneron Pharmaceuticals, Inc. | Common | 75886F107 | 59,086 | 146,237 | SH | SOLE | 146,237 | 0 | 0 | ||
Repligen Corporation | Common | 759916109 | 2,146 | 38,700 | SH | SOLE | 38,700 | 0 | 0 | ||
ResMed Inc. | Common | 761152107 | 6,762 | 58,630 | SH | SOLE | 58,630 | 0 | 0 | ||
Revance Therapeutics, Inc. | Common | 761330109 | 1,936 | 77,919 | SH | SOLE | 77,919 | 0 | 0 | ||
Rhythm Pharmaceuticals, Inc. | Sponsored ADR | 76243J105 | 726 | 24,890 | SH | SOLE | 24,890 | 0 | 0 | ||
The RMR Group Inc. | Class A | 74967R106 | 494 | 5,323 | SH | SOLE | 5,323 | 0 | 0 | ||
Sabra Health Care REIT, Inc. | Common | 78573L106 | 16,753 | 724,606 | SH | SOLE | 724,606 | 0 | 0 | ||
Sage Therapeutics, Inc. | Common | 78667J108 | 20,285 | 143,614 | SH | SOLE | 143,614 | 0 | 0 | ||
Sangamo Therapeutics, Inc. | Common | 800677106 | 2,914 | 171,889 | SH | SOLE | 171,889 | 0 | 0 | ||
Sanofi | Sponsored ADR | 80105N105 | 8,036 | 179,900 | SH | SOLE | 179,900 | 0 | 0 | ||
Sarepta Therapeutics, Inc. | Common | 803607100 | 36,046 | 223,182 | SH | SOLE | 223,182 | 0 | 0 | ||
Seattle Genetics, Inc. | Common | 812578102 | 21,549 | 279,417 | SH | SOLE | 279,417 | 0 | 0 | ||
Senior Housing Properties Trust | Common | 81721M109 | 11,353 | 646,554 | SH | SOLE | 646,554 | 0 | 0 | ||
Shire plc | Shares | 82481R106 | 6,565 | 36,216 | SH | SOLE | 36,216 | 0 | 0 | ||
Smith & Nephew plc | Sponsored ADR | 83175M205 | 6,879 | 185,478 | SH | SOLE | 185,478 | 0 | 0 | ||
Spark Therapeutics, Inc. | Common | 84652J103 | 1,203 | 22,046 | SH | SOLE | 22,046 | 0 | 0 | ||
SPDR S&P Biotech ETF | S&P Biotech ETF | 78464A870 | 12,367 | 129,000 | SH | SOLE | 129,000 | 0 | 0 | ||
Spectrum Pharmaceuticals, Inc. | Common | 84763A108 | 1,926 | 114,670 | SH | SOLE | 114,670 | 0 | 0 | ||
STERIS plc | Shares | G84720104 | 4,027 | 35,203 | SH | SOLE | 35,203 | 0 | 0 | ||
Stryker Corporation | Common | 863667101 | 28,506 | 160,432 | SH | SOLE | 160,432 | 0 | 0 | ||
Sutro Biopharma, Inc. | Common | 869367102 | 3,750 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
Syndax Pharmaceuticals, Inc. | Common | 87164F105 | 1,616 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
Teleflex Incorporated | Common | 879369106 | 1,697 | 6,379 | SH | SOLE | 6,379 | 0 | 0 | ||
Teligent, Inc. | Common | 87960W104 | 401 | 101,458 | SH | SOLE | 101,458 | 0 | 0 | ||
Tenet Healthcare Corporation | Common | 88033G407 | 4,682 | 164,500 | SH | SOLE | 164,500 | 0 | 0 | ||
TESARO, Inc. | Common | 881569107 | 3,705 | 94,970 | SH | SOLE | 94,970 | 0 | 0 | ||
Tetraphase Pharmaceuticals, Inc. | Common | 88165N105 | 2,372 | 859,322 | SH | SOLE | 859,322 | 0 | 0 | ||
Teva Pharmaceutical Industries Limited | Sponsored ADR | 881624209 | 20,096 | 932,948 | SH | SOLE | 932,948 | 0 | 0 | ||
Theravance Biopharma, Inc. | Common | G8807B106 | 264 | 8,083 | SH | SOLE | 8,083 | 0 | 0 | ||
Thermo Fisher Scientific Inc. | Common | 883556102 | 44,031 | 180,395 | SH | SOLE | 180,395 | 0 | 0 | ||
Trillium Therapeutics Inc. | Common | 89620X506 | 2,717 | 468,399 | SH | SOLE | 468,399 | 0 | 0 | ||
Ultragenyx Pharmaceutical Inc. | Common | 90400D108 | 5,875 | 76,958 | SH | SOLE | 76,958 | 0 | 0 | ||
uniQure N.V. | Shares | N90064101 | 1,373 | 37,741 | SH | SOLE | 37,741 | 0 | 0 | ||
United Therapeutics Corporation | Class B | 91307C102 | 5,276 | 41,261 | SH | SOLE | 41,261 | 0 | 0 | ||
Unitedhealth Group Incorporated | Common | 91324P102 | 91,647 | 344,486 | SH | SOLE | 344,486 | 0 | 0 | ||
Varian Medical Systems, Inc. | Common | 92220P105 | 2,936 | 26,227 | SH | SOLE | 26,227 | 0 | 0 | ||
Ventas, Inc. | Common | 92276F100 | 5,356 | 98,496 | SH | SOLE | 98,496 | 0 | 0 | ||
Verona Pharma plc | Sponsored ADR | 925050106 | 3,440 | 275,000 | SH | SOLE | 275,000 | 0 | 0 | ||
Vertex Pharmaceuticals Incorporated | Common | 92532F100 | 78,683 | 408,235 | SH | SOLE | 408,235 | 0 | 0 | ||
Waters Corporation | Common | 941848103 | 2,103 | 10,800 | SH | SOLE | 10,800 | 0 | 0 | ||
Welltower Inc. | Common | 95040Q104 | 2,930 | 45,560 | SH | SOLE | 45,560 | 0 | 0 | ||
Wright Medical Group N.V. | Ordinary Shares | N96617118 | 7,742 | 266,781 | SH | SOLE | 266,781 | 0 | 0 | ||
Zimmer Biomet Holdings, Inc. | Common | 98956P102 | 15,625 | 118,846 | SH | SOLE | 118,846 | 0 | 0 | ||
Zoetis Inc. | Class A | 98978V103 | 20,822 | 227,415 | SH | SOLE | 227,415 | 0 | 0 | ||
Zogenix, Inc. | Common | 98978L204 | 3,283 | 66,182 | SH | SOLE | 66,182 | 0 | 0 |